MOre REsponse on Cardiac Resynchronization Therapy (CRT) with MultiPointPacing (MPP) - More-CRT MPP

St Jude Medical India Pvt Ltd0 个研究点目标入组 6,898 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Eligible patients will meet ALL the following:
•Meets the current ESC or ACCF/AHA/HRS Class I or Class IIa indications for CRT implant (including upgrades from single or dual chamber ICDs)
•Must be willing and able to comply with study requirements
•Must indicate their understanding of the study and willingness to participate by signing an appropriate informed consent form

•Patients will be excluded if they meet ANY of the following criteria:
•Already had a CRT device implanted
•Myocardial Infarction, unstable angina within 40 days prior the enrollment
•Recent cardiac revascularization (PTCA, Stent or CABG) in the 4 weeks prior to enrollment or planned for the 3 months following
•Cerebrovascular Accident (CVA) or Transient Ischemic Attack (TIA) in the 3 months prior the enrollment
•Primary valvular disease requiring surgical correction
•Atrial Fibrillation:
•ï?¼Persistent AF at the time of enrollment
•ï?¼Permanent AF not treated with AV node ablation within 2 weeks from the CRT implant
•ï?¼History or incidence of Paroxysmal or Persistent AF within 30 days prior the enrollment
•Unable to comply with the follow up schedule
•Less than 18 years of age
•Pregnant or are planning to become pregnant during the duration of the investigation
•Classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 12 months
•Undergone a cardiac transplantation
•Life expectancy < 12 months
•Currently participating in any other clinical investigation

发起方

St Jude Medical India Pvt Ltd